ADVA
16.11.2021 09:02:12 CET | Business Wire | Press release
ADVA (FSE: ADV) today announced that it’s playing a key role in three research projects focused on significantly increasing the capacity of optical networks by using space division multiplexing (SDM) technology. Partly funded by Germany’s Federal Ministry of Education and Research (BMBF), the initiatives aim to transform optical transport systems by utilizing several parallel transmission paths. The research will focus on new ways to tackle the exponential rise in data traffic while continuing to reduce cost per bit. Running for three years, the projects will develop and demonstrate solutions to enable the next generation of high-performance networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005052/en/
“With new data-intensive applications such as automated driving, smart cities and IoT services, a paradigm shift is needed in the architecture of backbone networks. Annual growth rates in internet traffic are predicted to exceed 25%. That means digital infrastructure will have to handle three times as much traffic every five years and a hundred times as much in just two decades. Our role in these projects will help to massively increase network capacity in an economical and energy-efficient way,” said Christoph Glingener, CTO, ADVA. “SDM technology will be key to tomorrow’s transport infrastructure. By combining time, frequency and space division multiplexing, we can tackle the bottlenecks that are already emerging and support the digital transformation of our society.”
The projects feature a consortium of industry and research partners working to harness the potential of space multiplexing in fiber optic networks. That requires solving challenges and developing novel solutions in several key technology areas. These include a new generation of terminals to light up large chunks of capacity in a “rack-and-stack” fashion, optical switching nodes and amplifiers tailored to handle a large number of parallel signal paths, as well as disruptive innovation on new fibers. ADVA is leading the “Scalable terminal architectures and subsystems for fiber optic space multiplexing (STARFALL)” project, aimed at highly-integrated terminals for data center interconnects, as well as the “Wavelength selective switches for optical space multiplex (WESORAM)” project focused on novel optical switch architectures. ADVA’s team will also play a central role in the “Multi-core fibers and amplifiers with the highest capacity (Multi-Cap)” project, which will advance fiber transmission and optical amplification for SDM applications.
“These partner initiatives are a crucial step in confronting the mobile data crunch and enabling the continued digitalization of all areas of our lives. The solutions we’re developing here will empower operators to keep pace with enormous traffic growth while facilitating autonomous, zero-touch operations,” commented Jörg-Peter Elbers, SVP, advanced technology, ADVA. “SDM techniques will be fundamental to the next stage in the evolution of the data landscape. They provide an opportunity to sidestep the Shannon Limit and ensure our networks won’t be outstripped by the pace of innovation in other areas. Once again, our team is at the forefront, leading the way towards scalable and sustainable optical networks of the future.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005052/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Convenes Global Supply Chain Leaders at Kinexions North America to Advance Agentic AI and Decision Orchestration28.5.2026 13:00:00 CEST | Press release
Annual conference brings customers, partners, and industry leaders together to explore how enterprises are turning decisions into coordinated action Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, is set to host Kinexions North America kicking off next week from June 1-3 at The Cosmopolitan of Las Vegas. The company’s flagship conference will bring together global supply chain, business and technology leaders for three days of product innovation, customer insights, and peer networking as Kinaxis continues to advance its focus on AI-driven decision making across the supply chain industry. This year’s event will spotlight how organizations are applying agentic AI and orchestration, moving beyond insight to execution, and increasingly from decisions to coordinated action. Speakers from global organizations including Merck, Bristol Myers Squibb, Unilever, British American Tobacco, Qualcomm, ExxonMobil, The Hershey Company, Scotts Miracle-Gro, and
Amadeus Redefines Travel Advertising to Help Brands Capture Demand Earlier28.5.2026 13:00:00 CEST | Press release
Developed in collaboration with Accenture, the AI-powered platform helps travel brands make smarter advertising decisions earlier and drive profitable demand through greater control, transparency, efficiency and performance. Amadeus today introduced the Amadeus Travel Advertising Platform at its Advertising Summit in Nice, France. Leveraging Accenture’s agentic framework for campaign execution, the platform outlines a new approach designed to help travel companies make faster, smarter advertising decisions based on where demand is forming — not just where it has already converted. Travel advertising has become increasingly complex, fragmented across channels and often driven by historical performance signals that arrive too late to capture emerging demand. As travelers plan trips across AI chatbots, search, social, metasearch, content platforms and OTAs long before booking, travel brands face rising acquisition costs and growing pressure to prove return on investment. The Amadeus Trave
Compass Pathways Elects Kathleen Tregoning to Board of Directors28.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding biopharmaceutical companies through periods of growth and transformation, with expertise spanning corporate strategy, external affairs, public policy and patient access. “With two successful Phase 3 trials meeting the primary endpoint, a transformative clinical profile for COMP360, and a rolling NDA submission and review now underway, Compass is strongly positioned to make our goal of securing an FDA approval a reality. Compass is entering a stage where experience in external engagement, public policy, and patient access matters more
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)28.5.2026 12:28:00 CEST | Press release
IND enables initiation of U.S. clinical development in PSP Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526387210/en/ “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now expand our clinical efforts in the U.S. to evaluate AZP2006’s potential to address PSP, a severe neurodegenerative disease with no approved disease-modifying therapies.” Dr. Artin Karapet, Chief Medical Officer, commented: “The FDA’s clearance of our IND for AZP2006 is a pivotal milestone, aligning U.S. and European regulatory pathways and enabling th
LMR by IFF Inaugurates New Experimental Field in Grasse28.5.2026 11:00:00 CEST | Press release
Furthering IFF’s leadership in natural ingredients for perfumery. LMR Naturals by IFF—a global leader in natural ingredients for perfumery, cosmetics and flavors—today inaugurated its new experimental field, Domaine des Naturels LMR. The field is dedicated to advancing research in natural ingredients, preserving Grasse’s agricultural heritage and expanding education in naturals. The inauguration, attended by Grasse Mayor Jérôme Viaud, a long-standing supporter of the perfume industry, underscores IFF and LMR’s ongoing commitment to the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527694524/en/ At Domaine des Naturels LMR, R&D experts research new natural species, variety breeding, cultivation methods and production techniques. “This inauguration reflects over two decades of continuous investment in Grasse and in naturals,” said Ana Paula Mendonça, president, Scent, IFF. “With Domaine des Naturels LMR, we are bri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom